In the news ... 2009

New warning of serious Intelence side effect

August 27, 2009

This week, the FDA announced an updated side effect warning for Tibotec's HIV drug, Intelence. This comes after reports of severe hypersensitivity reactions, usually occurring during the first 6 weeks of taking the drug. The new prescribing information warns that individuals using the drug who experience these side effects should immediately contact their health providers to discuss possibly stopping Intelence.

The side effects include severe skin reactions, including the life-threatening condition called Stevens-Johnson syndrome. Other hypersensitivity reactions include include fever, generally ill feeling, extreme tiredness, muscle or joint aches, blisters, oral lesions, eye inflammation, facial swelling and/or signs and symptoms of liver problems.